Literature DB >> 3091286

Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency.

D J Stewart, D Elsner, O Sommer, J Holtz, E Bassenge.   

Abstract

The study of venodilator tolerance to nitroglycerin has been complicated by reflex compensation and by problems in analyzing venous tone in the presence of multiple determinants of venous pressure. We assessed venous tone as total effective vascular compliance (TEVC) under autonomic blockade in six dogs, in the nontolerant state, and during a 5 day infusion of nitroglycerin (1.5 micrograms/kg/min). Under long-term treatment, baseline TEVC was unaffected and the nitroglycerin dose-response relationship for TEVC was shifted to greater than 10-fold higher doses, whereas baseline mean arterial pressure (MAP) was lowered by 17 +/- 3 mm Hg without any shift in nitroglycerin responsiveness. This lowering of MAP was observed only after autonomic blockade. In six additional dogs instrumented with aortic flow probes, nitroglycerin (1.5 micrograms/kg/min) induced a 15 +/- 1% decline in peripheral vascular resistance (PVR) under autonomic blockade, but with reflexes intact these dogs showed no change in PVR and a 21 +/- 10% increase in norepinephrine release rate. We conclude that modest long-term exposure to nitroglycerin results in tolerance to its venodilating effects, whereas arteriolar action is maintained. This tolerance-induced shift in action from venous toward arteriolar dilation is normally masked by compensatory reflexes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091286     DOI: 10.1161/01.cir.74.3.573

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  Avoiding nitrate tolerance.

Authors:  J C Cowan
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

Review 2.  Mechanisms of nitrate tolerance: a review.

Authors:  R J Katz
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

3.  Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state.

Authors:  E Bassenge; B Fink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

4.  Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.

Authors:  A Mülsch; R Busse; I Winter; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

5.  Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.

Authors:  G Abou-Mohamed; W H Kaesemeyer; R B Caldwell; R W Caldwell
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Role of calcium-dependent K+ channels in the regulation of arterial and venous tone by nitric oxide in pigs.

Authors:  J Zanzinger; J Czachurski; H Seller
Journal:  Pflugers Arch       Date:  1996-08       Impact factor: 3.657

Review 7.  Clinical relevance of endothelium-derived relaxing factor (EDRF).

Authors:  E Bassenge
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

8.  Chronic nitroglycerine administration reduces endothelial nitric oxide production in rabbit mesenteric resistance artery.

Authors:  Tamao Yamamoto; Junko Kajikuri; Yoshimasa Watanabe; Yoshikatsu Suzuki; Kaoru Suzumori; Takeo Itoh
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 9.  Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.

Authors:  U Thadani; T Whitsett
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 10.  Mechanisms of nitrate tolerance.

Authors:  H L Fung; J A Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.